The Seattle Translational Tumor Research (STTR) has substantial infrastructure and experience building partnerships for collaborative research, particularly between BBI’s founding organizations. The BBI-STTR Precision Medicine Partnership Platform provides operational support for implementing Requests for Proposal (RFPs) and organizing workshops. It also provides regulatory support for BBI member grant recipients in specimen/subject profiling, IRB applications, consent guidance, and protocols.

The BBI-STTR Precision Medicine Partnership Platform is overseen by Dr. Eric Holland, MD, PhD., the Director of STTR. Dr. Holland is Senior Vice President and Director of the Human Biology Division of the Fred Hutchinson Cancer Research Center and Professor of Neurological Surgery at the University of Washington.